GlassScriptPhysician profile
Thomas Furgason
NPI 1295739779
$1,281.80
in general payments reported to CMS, 2019-2025
20 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $70.87 · 2021: $72.16 · 2022: $148 · 2023: $131 · 2024: $192 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.98 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $349.94 | 2019-2025 | Argos, Clareon Panoptix Pro, Hydrus Microstent |
| Regeneron Healthcare Solutions, INC. | $177.76 | 2019-2025 | Eylea, Eylea Hd |
| Mallinckrodt Hospital Products INC. | $173.42 | 2024-2025 | Acthar |
| Abbvie INC. | $90.56 | 2023-2025 | |
| Kala Pharmaceuticals, INC. | $75.30 | 2019-2020 | |
| Horizon Therapeutics Plc | $60.20 | 2022-2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $44.97 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $43.09 | 2019 | |
| Astellas Pharma US INC | $39.51 | 2023-2024 | Izervay |
| Aerie Pharmaceuticals, INC. | $32.76 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.83 | 2019 | |
| Dompe US, INC. | $27.14 | 2025 | Oxervate |
| Thea Pharma INC. | $22.03 | 2022 | |
| Amgen INC. | $21.25 | 2025 | Tepezza |
| Shire North American Group INC | $20.50 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Allergan, INC. | $15.18 | 2021 | |
| Lkc Technologies, INC. | $14.19 | 2025 | |
| Oyster Point Pharma, INC. | $12.45 | 2022 | |
| Omeros Corporation | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Furgason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.